Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2025 · second_quarter · Q2
Service member quality of life issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2025 · second_quarter · Q2
Source: Senate LDA
Heart Health Enhancement through Access to Research and Training Act
Client: WOMENHEART · Firm: CURA STRATEGIES
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Heart Health Enhancement through Access to Research and Training Act
Client: WOMENHEART · Firm: CURA STRATEGIES
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Federal funding for PKD research.
Policies to encourage organ donation.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2025 · first_quarter · Q1
Service member quality of life issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2025 · first_quarter · Q1
Federal funding for PKD research.
Policies to encourage organ donation.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2024 · fourth_quarter · Q4
Servicemember quality-of-life provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2024 · fourth_quarter · Q4
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2024 · fourth_quarter · RR
Servicemember quality-of-life provisions
PKD FOUNDATION via CURA STRATEGIES
2024 · third_quarter · Q3
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2024 · second_quarter · Q2
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOMENHEART via CURA STRATEGIES
2024 · first_quarter · 1T
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2024 · first_quarter · Q1
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOMENHEART via CURA STRATEGIES
2023 · fourth_quarter · 4A
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOMENHEART via CURA STRATEGIES
2023 · fourth_quarter · RR
Policies supporting female cardiovascular disease patients, research around cardiovascular disease
PKD FOUNDATION via CURA STRATEGIES
2023 · fourth_quarter · Q4
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2023 · third_quarter · Q3
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2023 · second_quarter · Q2
Passage of the Access to AEDs Act, potential Peer Support research legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2023 · second_quarter · Q2
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2023 · first_quarter · Q1
Passage of the Access to AEDs Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2023 · first_quarter · Q1
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2022 · fourth_quarter · Q4
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2022 · fourth_quarter · Q4
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act, introduction of racial disparities in transplant care legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2022 · third_quarter · Q3
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act, introduction of racial disparities in transplant care legislation
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2022 · third_quarter · Q3
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2022 · second_quarter · Q2
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2022 · second_quarter · RR
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
PKD FOUNDATION via CURA STRATEGIES
2022 · second_quarter · Q2
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act, introduction of racial disparities in transplant care legislation
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2022 · first_quarter · Q1
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act, introduction of racial disparities in transplant care legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2021 · fourth_quarter · Q4
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2021 · third_quarter · Q3
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE